Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80
Organisation › Details

GW Pharmaceuticals plc

GW Pharmaceuticals plc (AIM:GWP) was founded in 1998 and is listed on the AiM, a market of the London Stock Exchange. Operating under licence from the UK Home Office, the company researches and develops cannabinoid pharmaceutical products for patients who suffer from a range of serious ailments, in particular MS and cancer pain. GW has assembled a large in-house scientific team with expertise in cannabinoid science as well as experience in the development of both plant based prescription pharmaceutical products and medicines containing controlled substances. GW occupies a world leading position in cannabinoids and has developed an extensive international network of the most prominent scientists in the field. *

 

Period Start 1998-01-01 established
Products Industry pharmaceutical
  Industry 2 Epidiolex®
Person Person Gover, Justin (GW Pharmaceuticals 202102 CEO)
     
Region Region Salisbury, Wiltshire
  Country United Kingdom (GB)
  Street Porton Down Science Park
  City SP4 0JQ Salisbury
  Tel +44-1980-557000
    Address record changed: 2020-12-02
     
Basic data Employees D: 101 to 500 (2006-09-30)
  Currency GBP
  Annual sales 1,981,000 (turnover (2005/06) 2006-09-30)
  Profit 11,915,000 (2006-09-30)
  Cash 19,900,000 (2006-09-30)
     
    * Document for �About Section�: 
     
   
Record changed: 2021-02-05

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for GW Pharmaceuticals plc


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80




» top